Status: Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
The purpose of this 26 week study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.
Participants needed: 150
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Renibus Therapeutics, Inc.Updated: Jun 18, 2026Locations: 21
Eligibility criteria
Written informed consent. [+7]
Any participant deemed by the Investigator to be an inappropriate candidate for... [+25]